Syncope and Neuroleptic malignant syndrome - from FDA reports
Neuroleptic malignant syndrome is reported only by a few people with Syncope. We study 4 people who have Neuroleptic malignant syndrome and Syncope from FDA . Find out below who they are, other conditions they have and drugs they take.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jan, 20, 2018
4 people who have Syncope and Neuroleptic Malignant Syndrome are studied.
Number of reports submitted per year:
Gender of people who have Syncope and experience Neuroleptic Malignant Syndrome *:
- female: 25 %
- male: 75 %
Age of people who have Syncope and experience Neuroleptic Malignant Syndrome *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 50 %
Top co-existing conditions for these people *:
- Pneumonia (2 people, 50.00%)
- Chronic Obstructive Pulmonary Disease (1 person, 25.00%)
Most common drugs for these people *:
- Ranitidine (2 people, 50.00%)
- Ondansetron (2 people, 50.00%)
- Multaq (2 people, 50.00%)
- Lyrica (2 people, 50.00%)
- Humalog (2 people, 50.00%)
Top symptoms for these people *:
- Weight Decreased (2 people, 50.00%)
- Lung Cancer Metastatic (2 people, 50.00%)
- Appetite - Decreased (2 people, 50.00%)
- Pharyngolaryngeal Pain (1 person, 25.00%)
- Attention Deficit Hyperactivity Disorder (1 person, 25.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Neuroleptic malignant syndrome and Syncope?
- Check symptoms - is your neuroleptic malignant syndrome caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- Write a Post - share your experience related to the study
- More tools...
Expand the study to include reports from both FDA and eHealthMeNeuroleptic malignant syndrome and Syncope from FDA and eHealthMe reports
Syncope (loss of consciousness with an inability to maintain postural tone) can be treated by Florinef, Midodrine hydrochloride, Metoprolol succinate (latest reports from 74,775 Syncope patients)
Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) has been reported by people with schizophrenia, depression, bipolar disorder, psychotic disorder, parkinson's disease (latest reports from 9,926 Neuroleptic malignant syndrome patients).
Browse all symptoms of Syncopea b c d e f g h i j k l m n o p q r s t u v w x y z
Could your drugs cause Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Other conditions that could case Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Related publications that referenced our studies
- Ogłodek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
What would happen?
Can you answer these questions?
My son (age 21) has Spastic Diplegia resulting from premature birth. He has a large "startle response" when surprised and will even insist a companion hold popcorn in movies as he has, on occasion, thrown it in the air when startled. On 2 occasions in the past few years he has passed out in ...